PF-05280014 (a trastuzumab biosimilar) plus paclitaxel compared with reference trastuzumab plus paclitaxel for HER2-positive metastatic breast cancer: a randomised, double-blind st...

por Pegram, Mark D., Bondarenko, Igor, Zorzetto, Marina Moreira Costa, Hingmire, Sachin, Iwase, Hirotaka, Krivorotko, Petr V., Lee, Keun Seok, Li, Rubi K., Pikiel, Joanna, Aggarwal, Rajesh, Ewesuedo, Reginald, Freyman, Amy, Li, Ray, Vana, Alicia, Yin, Donghua, Zacharchuk, Charles, Tan-Chiu, Elizabeth
Publicado 2018

Neoadjuvant carboplatin in triple-negative breast cancer: results from NACATRINE, a randomized phase II clinical trial

por de Pádua Souza, Cristiano, Carneiro, Ana Suellen Barroso, de Oliveira Lessa, Ana Cecília, Lacerda, Domício Carvalho, Paiva, Carlos Eduardo, Zorzetto, Marina Moreira Costa, de Freitas, Ana Julia Aguiar, Santana, Iara Viana Vidigal, de Oliveira, Marco Antonio, Palmero, Edenir Inêz, Marques, Márcia Maria Chiquitelli, Reinert, Tomás
Publicado 2023